Atlas Trials

Outcome-related Factors in Patients With Metastatic Renal Cell Carcinoma Treated With Everolimus (ORCHIDEE)

Clinical trial NCT02338570 · TERMINATED

Trial details

NCT number
NCT02338570
Sponsor
Mario Negri Institute for Pharmacological Research
Status
TERMINATED
Phase
Phase 4
Study type
INTERVENTIONAL
Renal Cell Carcinoma
Start date
2015-07-01
Primary completion
2018-02-01
Enrollment
31

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.